We identified sets of lipids that were associated with each CSF biomarker and AD progression, suggesting that the role of lipids in AD pathology and progression is broader than their involvement in known pathological and cognitive aspects of AD and the influence of APOE ε4. Here, APOE is linked to Alzheimer disease.